| John Talley, MS, CCC-SLP/L | |
|
850 S 5th St, Allentown, PA 18103-3308 | |
| (610) 776-3578 | |
| Not Available |
| Full Name | John Talley |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 850 S 5th St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932501285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL011349 (Pennsylvania) | Primary |
| Provider Name | High Falls Speech Therapy Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114510963 PECOS PAC ID: 9638585029 Enrollment ID: O20210310000154 |
News Archive
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.
The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.
ERYtech Pharma is pleased to announce it has signed a collaborative research agreement with Genzyme Corporation to explore the feasibility of developing a novel therapeutic enzyme formulation using ERYtech's proprietary technology.
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
Obesity is an important factor contributing to chemotherapy resistance and increasing relapse rates among children with leukemia, according to recent findings published online first in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Talley, MS, CCC-SLP/L 850 S 5th St, Allentown, PA 18103-3308 Ph: (610) 776-3578 | John Talley, MS, CCC-SLP/L 850 S 5th St, Allentown, PA 18103-3308 Ph: (610) 776-3578 |
News Archive
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.
The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.
ERYtech Pharma is pleased to announce it has signed a collaborative research agreement with Genzyme Corporation to explore the feasibility of developing a novel therapeutic enzyme formulation using ERYtech's proprietary technology.
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
Obesity is an important factor contributing to chemotherapy resistance and increasing relapse rates among children with leukemia, according to recent findings published online first in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 2 days ago
Adrienne Westheim, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 930 Springhouse Rd, Allentown, PA 18104 Phone: 610-390-5014 Fax: 610-398-7134 | |
Bailey Mckeon, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1925 W Turner St, Allentown, PA 18104 Phone: 610-794-5264 | |
Sarah Wanuga, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Megan Pellek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Cedarbrook Rd, Allentown, PA 18104 Phone: 610-395-3727 Fax: 610-395-7919 | |
Cailee Carmella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4136 W Tilghman St Apt 5, Allentown, PA 18104 Phone: 484-822-6040 | |
Ellen Susan Krajcir, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Tiffany Ferreira, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 888-402-5846 |